ZLD 0.00% 63.0¢ zelira therapeutics limited

Ann: Zelda to Test Formulations Against Pancreatic Cancer, page-5

  1. 361 Posts.
    I could not agree more - you are absolutely correct. I cannot work out why the SP seems so stagnant particularly with Auscann (current TWH SP holders) is due to enter disallowed mid to late January 2017. The partnerships achieved already. . . . .
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.